Health
Newer Type 2 diabetes medications have heart and kidney disease benefits, too – Yahoo India News
Washington [US], September 28 (ANI): Two newer groups of medications prescribed primarily for Type 2 diabetes treatment (SGLT2 inhibitors and GLP-1 receptor agonists) could significantly reduce risks associated with chronic kidney disease (CKD) and heart dise…
Continue Reading
-
Business24 hours agoWhat Warren Buffett’s farewell letter means for Berkshire Hathaway investors
-
General24 hours agoEnvironment Bill passes Senate as Greens cut deal with Labor
-
General8 hours agoQantas terminal at Melbourne Airport evacuated and flights delayed due to fire
-
General23 hours agoCalls for states to change alcohol laws ahead of women’s ministers meeting
